American Health Packaging is recalling 375,921 bottles of Anastrozole Tablets (1 mg), a prescription medication used to treat breast cancer. This recall was initiated because of a failure in cleaning procedures at the manufacturing facility, which could lead to cross-contamination between different drug products. The affected medication was distributed nationwide in 30-count and 1,000-count bottles under the BluePoint Laboratories label.
A failure in the manufacturer's cleaning process creates a risk that traces of other medications could contaminate these tablets. Ingesting a drug contaminated with an unintended active ingredient could cause unpredictable side effects or adverse reactions, especially for patients with specific allergies or sensitivities.
Healthcare provider consultation and pharmacy refund.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.